IBM vs MDLZ Stock Comparison: Price, Growth & Valuation (2026)

Use MEXC Stock Compare for a detailed IBM vs MDLZ analysis. Compare IBM and MDLZ across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.

IBM vs MDLZ Stock Comparison Summary

IBM reported year-over-year revenue growth of 7.9%, compared with 6.9% for MDLZ. Their P/E ratios are 19.8x and 21.9x, dividend yields are 2.97% and 3.30%, and 30-day volatility levels are 31.9% and 18.5%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall neither stock has a clear lead based on the selected metrics.

Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.

IBM vs MDLZ Stock Return Comparison (1W)

IBMMDLZ

Compare the cumulative total returns of International Business Machines Corporation (IBM) and Mondelez International, Inc. (MDLZ) over the selected 1W period. Data as of 2026-09-25 12:00:00.

IBM vs MDLZ Key Equity Metrics Comparison Summary

International Business Machines Corporation (IBM) has a market capitalization of $212.44B and operates in the Information Technology sector, with its main business classified under IT Consulting & Other Services. Its latest quarterly revenue changed +7.9% year over year.

Mondelez International, Inc. (MDLZ) has a market capitalization of $76.90B and operates in the Consumer Staples sector, with its main business classified under Packaged Foods & Meats. Its latest quarterly revenue changed +6.9% year over year.

IBM vs MDLZ Key Stock Indicators

Comparison MetricInternational Business Machines Corporation
IBM
Mondelez International, Inc.
MDLZ
Comparison results

Stock Price & Returns

Latest delayed stock price with 1-day, 1-month and year-to-date returns.

$225.491D: -0.6%1M: -3.6%1Y: -19.4%$60.261D: -1.0%1M: -2.9%1Y: -3.8%MDLZWin

Market Capitalization

Total market value of the company's outstanding shares.

$212.44B$76.90BIBMWin

Sector & Industry

The company's market sector and primary industry classification.

Information Technology / IT Consulting & Other ServicesConsumer Staples / Packaged Foods & Meats--
Based on delayed market data, IBM is trading at $225.49, compared with $60.26 for MDLZ. Their market capitalizations are $212.44B and $76.90B, respectively. IBM operates in the Information Technology sector, while MDLZ belongs to Consumer Staples.
IBM vs MDLZ Growth & Profitability

Revenue Growth (YoY)

Year-over-year change in revenue.

+7.9%+6.9%IBMWin

EPS Growth (YoY)

Year-over-year change in earnings per share.

+81.6%-0.4%IBMWin

ROIC

Return generated from invested capital.

12.2%7.8%IBMWin

Gross Margin / Operating Margin

Profitability before and after operating expenses.

58.1% / 17.9%31.1% / 11.2%IBMWin
On growth, IBM posted revenue growth of +7.9% and TTM EPS growth of +81.6%. MDLZ, by comparison, posted revenue growth of +6.9% and TTM EPS growth of -0.4%.On profitability, IBM recorded a gross margin of 58.1%, an operating margin of 17.9%, and ROIC of 12.2%. For MDLZ, the corresponding figures were 31.1%, 11.2%, and 7.8%.Overall, IBM shows stronger overall growth and profitability.
IBM vs MDLZ Valuation & Balance Sheet

Free Cash Flow Yield

Free cash flow as a percentage of market capitalization.

6.5%4.0%IBMWin

Net Debt / EBITDA

Net debt relative to EBITDA; a negative value indicates net cash.

2.7x3.2xIBMWin

Dividend Yield / Payout Ratio

Dividend returns relative to share price and the share of earnings paid as dividends.

2.97% / 58.9%3.30% / 72.3%MDLZWin
IBM offers a higher free cash flow yield, indicating a less demanding valuation. IBM has the stronger balance sheet, while MDLZ provides the higher dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income.
IBM vs MDLZ Returns & Risk

Total Return (Dividend-Adjusted)

Cumulative return over 1, 5 and 10 years, including dividends.

1Y: -19.4%5Y: +70.2%10Y: +50.5%1Y: -3.8%5Y: +1.3%10Y: +39.6%IBMWin

30-Day Realized Volatility

Annualized volatility based on the past 30 days of daily returns.

31.9%18.5%MDLZWin

Beta (5Y vs S&P 500)

Sensitivity to market movements; above 1 indicates greater market volatility.

0.630.29MDLZWin
IBM has delivered stronger long-term returns, but IBM also shows higher recent volatility and market sensitivity.

IBM vs MDLZ Valuation & Dividend Metrics

Review IBM compared with MDLZ across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.

MetricInternational Business Machines Corporation
IBM
Mondelez International, Inc.
MDLZ
Comparison results

Market Cap

$212.44B$76.90BIBMWin

P/E (TTM)

19.8x21.9xIBMWin

P/S

3.1x1.9xMDLZWin

EV/EBITDA

15.2x16.2xIBMWin

Dividend Yield

2.97%3.30%MDLZWin

IBM vs MDLZ Profitability Over Time

Compare IBM and MDLZ across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.

TTM3Y Avg5Y Avg10Y Avg
IBM58.2%56.8%55.8%53.1%
MDLZ28.4%35.2%36.2%37.8%

Technical & Fundamental Stock Analysis

RSI (14, daily)Updated as of 2026-09-25 market close

IBM 41.35 • MDLZ 39.54

Measures short-term price momentum and helps identify possible overbought or oversold conditions.

50/200-DMA PositionUpdated as of 2026-09-25 market close

IBM 50D Below / 200D Below • MDLZ 50D Below / 200D Above

Shows whether the stock is trading above or below its medium- and long-term trend lines.

R&D % of Revenue

IBM 13.3% • MDLZ 0.0%

Shows how much of revenue is invested in research and development.

Share Count Trend (3Y)

IBM Increased • MDLZ Decreased

Shows whether the company's share count has increased or decreased over the past three years.

Company Profiles

International Business Machines Corporation

IT Consulting & Other Services

Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.

Mondelez International, Inc.

Packaged Foods & Meats

Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. Since that time, the firm has been a leading player in the global snack enclave with a presence in the biscuit (48% of sales as of the end of fiscal 2025), chocolate (33%), gum/candy (10%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm garners around one-third of its revenue from developing markets, around 40% from Europe, and more than one-fourth from North America.

Trade IBM & MDLZ Stock Futures on MEXC

Trade USDT-margined Stock Futures referencing IBM and MDLZ on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.

Everything You Need to Know About IBM vs MDLZ Stocks

What is MEXC Stock Compare?

MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.

Which metrics should I use to evaluate a company's growth?

Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.

How do IBM and MDLZ compare in growth and profitability?

In the latest reported period, IBM recorded revenue growth of +7.9% and TTM EPS growth of +81.6%, compared with +6.9% and -0.4% for MDLZ. IBM leads on both growth and profitability. This comparison is based on reported financial metrics and does not predict future performance.

What is the difference between P/E (TTM) and Forward P/E?

P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.

How do the risk profiles of IBM and MDLZ compare?

IBM has a 30-day realized volatility of 31.9% and a five-year Beta of 0.63, compared with 18.5% and 0.29 for MDLZ. IBM shows higher historical volatility and market sensitivity. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.

What do dividend yield and payout ratio indicate?

Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.

How should I compare a high-growth stock with a lower-valued stock?

A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.

Which is the better stock, IBM or MDLZ?

There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.

Can I trade IBM and MDLZ as RealStocks on MEXC?

Eligible users can trade IBM and MDLZ as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.

Disclaimer

The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.